Mabpharm Limited · HKEX:2181

Mabpharm Limited financial statements

Mabpharm Limited's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue629.4M258.2M87.2M55.9M82.9M014.1M23.9M4.69M
Cost of revenue107.8M38.8M11.9M15.4M16.8M0
Gross profit521.5M219.4M75.2M40.5M66.1M014.1M23.9M4.69M
Research and development49.3M75.2M123.2M147.9M263.6M120.4M134.2M89.0M21.6M
Selling, general and administrative511.3M28.9M21.0M22.0M21.3M18.5M90.5M34.4M4.87M
Operating income4.68M-119.7M-202.0M-226.3M-297.5M-186.2M-194.8M-148.1M-44.4M
Depreciation and amortization59.8M61.3M60.7M51.5M43.9M24.4M22.2M11.7M10.1M
EBITDA64.5M-58.3M-141.3M-174.7M-253.6M-161.8M-172.6M-136.4M-34.3M
Interest expense10.5M10.6M9.58M7.19M2.40M3.94M7.70M4.48M3.33M
Income before tax4.05M-127.9M-209.4M-210.8M-291.7M-184.6M-202.5M-152.6M-47.7M
Income tax-51.6M-199.0K2.48M-2.83M
Net income55.7M-127.9M-209.4M-210.6M-291.7M-188.6M-210.2M-124.9M-31.1M
Earnings per share, basic0.01-0.03-0.05-0.05-0.07-0.05-0.05-0.03-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents109.3M89.3M173.3M33.6M81.6M484.8M588.7M198.2M76.4M
Short-term investments015.0M0179.2M
Receivables163.9M96.1M19.4M9.53M793.0K1.22M6.88M2.27M484.0K
Inventory136.6M111.0M102.0M100.8M53.2M33.4M22.2M27.6M36.3M
Current assets434.5M365.8M342.2M201.1M247.8M569.1M955.1M260.8M154.9M
Property, plant and equipment569.0M614.2M686.5M704.0M561.0M512.6M332.4M122.8M113.1M
Total assets1.15B1.02B1.03B917.5M899.9M1.16B1.40B473.2M289.1M
Accounts payable30.2M11.7M10.0M16.6M12.9M4.52M4.51M1.80M1.09M
Current liabilities534.3M312.1M316.2M188.4M235.0M202.6M270.3M156.4M70.9M
Long-term debt66.3M165.5M101.5M84.7M0065.0M65.0M
Total debt326.9M293.1M260.1M126.3M46.4M40.3M214.3M105.0M75.0M
Total liabilities996.6M927.3M829.9M516.6M297.9M281.6M342.8M223.7M135.9M
Shareholders' equity157.4M88.9M205.1M400.9M602.0M881.5M1.05B249.6M99.8M
Shares outstanding4.12B4.12B4.12B4.12B4.12B4.12B4.12B4.12B4.12B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations80.8M-4.10M57.4M-56.9M-199.5M-147.2M-136.6M-61.9M-65.1M
Capital spending-104.0M-59.5M-19.0M-125.1M-148.7M-197.2M-113.6M-90.9M-13.1M
Free cash flow-23.2M-63.6M38.4M-182.0M-348.1M-344.5M-250.2M-152.8M-78.3M
Cash from investing-64.2M-98.2M-3.50M-105.0M-179.4M156.0M-413.1M-82.7M-13.6M
Cash from financing3.29M18.3M85.6M112.3M-17.8M-80.5M922.8M256.8M16.9M
Share buybacks01.03B410.5M0
Change in cash19.9M-84.0M139.8M-48.0M-403.3M-103.9M390.5M121.8M-33.2M